Pharmaceutical group · United States
A group of 6 companies with 10 medicines in 2 countries.
6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| HYDASE150 units/ml · Injectable | Hyaluronidase | United States | Not marketed | 2005 |
| ANASED100 mg / ml · Solution | Xylazine | Canada | Cancelled | 1987 |
| ANASED20 mg / ml · Solution | Xylazine | Canada | Cancelled | 1995 |
| FLURESS0.4 % + 0.25 % · Solution | Oxybuprocaine, Fluorescein | Canada | Cancelled | 1996 |
| IC-GREEN25 mg / vial · Powder | Indocyanine green | Canada | Cancelled | 1994 |
| INDIGO CARMINE0.8 % · Solution | Indigo carmine | Canada | Cancelled | 1994 |
| PALONOSETRON HYDROCHLORIDE0.25mg(base)/5ml · Injectable | Palonosetron | United States | tentative | 2015 |
| TIMOLOL MALEATE0.5% · Solution | Timolol | United States | tentative | 2015 |
| TOLAZINE INJECTION100 mg / ml · Solution | Tolazoline | Canada | Cancelled | 1996 |
| YOBINE INJECTABLE2 mg / ml · Solution | Yohimbin | Canada | Cancelled | 1989 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 7 | 0 | 7 | CompaniesAll medicines |
| United States | 3 | 1 | 2 | CompaniesAll medicines |
Also in the registers of Colombia
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Keep Akorn’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.
